SCHEMBL3365101

SCHEMBL3365101

CCCCNS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158769 0.92 PPARA (0.58) —
SCHEMBL11221936 0.90 PPARA (0.61) —
SCHEMBL10930258 0.90 PPARA (0.61) —
SCHEMBL1111454 0.83 — —
Butyl(Butylsulfamoyl)Amine SCHEMBL2486301 0.78 CA1 (1.00) —
SCHEMBL245387 0.78 — —
SCHEMBL2111624 0.76 — —
SCHEMBL8679104 0.76 CA1 (0.67) —
SCHEMBL277303 0.76 CA1 (0.67) —
SCHEMBL487521 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303503-B1 ANILINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-01-27 — — EP disclosed
EP-1797077-A4 BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF I ASTRAZENECA AB (SE) 2009-04-01 — — EP disclosed
EP-1311475-B1 AMINOCYCLOHEXANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-08-06 — — EP disclosed
US-7335687-B2 2,3-Oxidosqualene-lanosterol cyclase inhibitors HOFFMANN-LA ROCHE INC. (US) 2008-02-26 — — US disclosed
EP-1797077-A1 BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF I AstraZeneca AB (SE) 2007-06-20 — — EP disclosed
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 — — EP disclosed
US-7202258-B2 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 2007-04-10 — — US disclosed
US-7189756-B2 Pyrrolidine derivatives HOFFMAN-LA ROCHE INC. (US) 2007-03-13 — — US disclosed
US-7102007-B2 Dihydroindole and tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2006-09-05 — — US disclosed
US-7071212-B2 N-(4-carbamimidoyl-phenyl)-glycine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-07-04 — — US disclosed
US-4704388-A ANTIULCER, CYTOPROTECTIVE RORER PHARMACEUTICAL CORPORATION (US) 1987-11-03 — — US disclosed
EP-0185684-A4 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES. RORER INTERNAT OVERSEAS INC (US) 1986-09-22 — — EP disclosed
EP-0185684-A1 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1986-07-02 — — EP disclosed
WO-1985005105-A1 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1985-11-21 — — WO disclosed
US-4327034-A CHEMICAL INTERMEDIATE PREPARED FROM A SULFAMIC ACID HALIDE AND A HALOGEN COMPOUND BASF AKTIENGESELLSCHAFT (DE) 1982-04-27 — — US disclosed
EP-0009054-A1 N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same MERCK & CO. INC. (US) 1980-04-02 — — EP disclosed
US-4115573-A N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same MERCK & CO., INC. (US) 1978-09-19 — — US disclosed
US-4096181-A Substituted sulfamic acid halides BASF AKTIENGESELLSCHAFT (DT) 1978-06-20 — — US disclosed
US-3992444-A BY REACTION OF A SULFAMIC ACID WITH AN ACID HALIDE BASF AKTIENGESELLSCHAFT (DT) 1976-11-16 — — US disclosed
US-3935201-A Production of 2,1,3-benzothiadiazin-4-one-2,2-dioxides BASF AKTIENGESELLSCHAFT (DT) 1976-01-27 — — US disclosed
Send feedback